Omaveloxolone clinical trials

A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

This study looks at a medicine called omaveloxolone (SKYCLARYS®) for children and teenagers aged 2 to 15 with Friedreich’s Ataxia. It aims to see how well it works and if it's safe, as it's currently only approved for adults.